CXCL12 and familial pancreatic carcinoma: In the absence of serum growth factors, CXCL12 stimulation led to the 29–33% induction of growth in pancreatic cancer cells, whereas a moderate increase (11–13%) was observed in the presence of serum growth factors (Figure 1C).